SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-318484
Filing Date
2017-10-25
Accepted
2017-10-25 07:32:03
Documents
3
Period of Report
2017-10-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d477242d8k.htm 8-K 17789
2 EX-99.1 d477242dex991.htm EX-99.1 9728
3 GRAPHIC g477242g20u11.jpg GRAPHIC 4289
  Complete submission text file 0001193125-17-318484.txt   34888
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37490 | Film No.: 171152069
SIC: 2834 Pharmaceutical Preparations